BIOMAT Database Logo BIOMAT Database Logo

Attempts to infect rhesus monkeys with human type 4 adenovirus. 1968

F A Pedreira, and N M Tauraso, and A E Palmer, and A Shelokov, and R L Kirschstein

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D003168 Complement Fixation Tests Serologic tests based on inactivation of complement by the antigen-antibody complex (stage 1). Binding of free complement can be visualized by addition of a second antigen-antibody system such as red cells and appropriate red cell antibody (hemolysin) requiring complement for its completion (stage 2). Failure of the red cells to lyse indicates that a specific antigen-antibody reaction has taken place in stage 1. If red cells lyse, free complement is present indicating no antigen-antibody reaction occurred in stage 1. Complement Absorption Test, Conglutinating,Conglutination Reaction,Conglutinating Complement Absorption Test,Complement Fixation Test,Conglutination Reactions,Fixation Test, Complement,Fixation Tests, Complement,Reaction, Conglutination,Reactions, Conglutination,Test, Complement Fixation,Tests, Complement Fixation
D003588 Cytopathogenic Effect, Viral Visible morphologic changes in cells infected with viruses. It includes shutdown of cellular RNA and protein synthesis, cell fusion, release of lysosomal enzymes, changes in cell membrane permeability, diffuse changes in intracellular structures, presence of viral inclusion bodies, and chromosomal aberrations. It excludes malignant transformation, which is CELL TRANSFORMATION, VIRAL. Viral cytopathogenic effects provide a valuable method for identifying and classifying the infecting viruses. Cytopathic Effect, Viral,Viral Cytopathogenic Effect,Cytopathic Effects, Viral,Cytopathogenic Effects, Viral,Effect, Viral Cytopathic,Effect, Viral Cytopathogenic,Effects, Viral Cytopathic,Effects, Viral Cytopathogenic,Viral Cytopathic Effect,Viral Cytopathic Effects,Viral Cytopathogenic Effects
D000256 Adenoviridae A family of non-enveloped viruses infecting mammals (MASTADENOVIRUS) and birds (AVIADENOVIRUS) or both (ATADENOVIRUS). Infections may be asymptomatic or result in a variety of diseases. Adenoviruses,Ichtadenovirus,Adenovirus,Ichtadenoviruses
D000257 Adenoviridae Infections Virus diseases caused by the ADENOVIRIDAE. Adenovirus Infections,Infections, Adenoviridae,Infections, Adenovirus,Adenoviridae Infection,Adenovirus Infection,Infection, Adenoviridae,Infection, Adenovirus

Related Publications

F A Pedreira, and N M Tauraso, and A E Palmer, and A Shelokov, and R L Kirschstein
Quantity of dengue virus required to infect rhesus monkeys.
January 1985, Transactions of the Royal Society of Tropical Medicine and Hygiene,
F A Pedreira, and N M Tauraso, and A E Palmer, and A Shelokov, and R L Kirschstein
Attempts to infect experimentally immunosuppressed iris monkeys (Macaca iris) with Brugia malayi.
December 1983, The Southeast Asian journal of tropical medicine and public health,
F A Pedreira, and N M Tauraso, and A E Palmer, and A Shelokov, and R L Kirschstein
Attempts to infect African green monkeys by oral administration of poliomyelitis virus.
March 1947, American journal of hygiene,
F A Pedreira, and N M Tauraso, and A E Palmer, and A Shelokov, and R L Kirschstein
Attempts to produce cancer in rhesus monkeys with carcinogenic hydrocarbons and estrogens.
March 1948, Cancer research,
F A Pedreira, and N M Tauraso, and A E Palmer, and A Shelokov, and R L Kirschstein
Attempts to Infect Swine with S. suipestifer.
March 1945, Canadian journal of comparative medicine and veterinary science,
F A Pedreira, and N M Tauraso, and A E Palmer, and A Shelokov, and R L Kirschstein
Attempts to find human adenovirus type-12 tumor antigens in human tumors.
February 1968, Journal of the National Cancer Institute,
F A Pedreira, and N M Tauraso, and A E Palmer, and A Shelokov, and R L Kirschstein
Determination and analysis of the complete genomic sequence of avian hepatitis E virus (avian HEV) and attempts to infect rhesus monkeys with avian HEV.
June 2004, The Journal of general virology,
F A Pedreira, and N M Tauraso, and A E Palmer, and A Shelokov, and R L Kirschstein
Adenovirus enteritis in SIV-infected rhesus monkeys.
November 1989, The Journal of infectious diseases,
F A Pedreira, and N M Tauraso, and A E Palmer, and A Shelokov, and R L Kirschstein
Evidence that adenovirus type 2 can infect human placenta in vitro.
January 1981, Placenta,
F A Pedreira, and N M Tauraso, and A E Palmer, and A Shelokov, and R L Kirschstein
Synthetic epikeratoplasty in rhesus monkeys with human type IV collagen.
January 1993, Cornea,
Copied contents to your clipboard!